Second, tumor cells undergoing EMT significantly modify the composition of cytoskeletal intermediate filaments with the repression of keratin and expression of vimentin that is believed to be responsible for the adoption of a mesenchymal shape and increased motility and is regarded as the main and conventional canonical marker of EMT22. This evidence concerns the gene VIM and neoplasm.